RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference Feb 18, 2021
Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva Feb 16, 2021 Life Science
Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23% Feb 12, 2021 Life Science
Healthcare Roundup – Merck and Teva in talks to join COVID-19 vaccine production, Aurora Cannabis shares up after FQ2 revenue rides high on medical cannabis strength Feb 11, 2021 Life Science
Healthcare Roundup – Generex announces receipt of $2M for its COVID-19 vaccine development; I-Mab’s cancer therapy greenlighted in China for phase 1 trial Feb 10, 2021 Life Science
Healthcare Roundup – Bristol Myers announce new late-stage data for Opdivo/ Cabometyx combo in kidney cancer; Merck antiviral molnupiravir effective in preventing COVID-19 in lung tissue Feb 10, 2021 Life Science
Healthcare Roundup – Bristol Myers Squibb’s Inrebic nabs European Commission approval; Pfizer/BioNTech double the vaccine supply to EU Feb 8, 2021 Life Science
Healthcare Roundup – Clover shares close up nearly 6% after Chamath Palihapitiya rebukes Hindenburg report; Bristol Myers Squibb wins FDA approval for lymphoma treatment Breyanzi Feb 5, 2021 Life Science
Healthcare Roundup – Omega Health buys 24 facilities for $510M; Align Tech up 13% as analysts view Q4 2020 results favorably Feb 4, 2021 Life Science
Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s disease Feb 3, 2021 Life Science
Healthcare Roundup – AstraZeneca gets European nod for COVID-19 vaccine; eHealth announces $225M strategic investment from H.I.G. capital Jan 30, 2021 Life Science
Healthcare Roundup – Pfizer’s setback can hurt others with JAK inhibitors, EyePoint surges after Cantor Fitzgerald nod; potential of EYP-1901 cited Jan 27, 2021 Life Science
Healthcare Roundup – Lilly bamlanivimab combo therapy lowers COVID-19 hospitalizations, JNJ earnings release brightens U.S. biopharma outlook Jan 26, 2021 Life Science
Healthcare Roundup- Merck discontinues development of V590 and V591 COVID-19 vaccine candidates, Moderna’s COVID-19 jab retains neutralizing activity against emerging virus variants Jan 25, 2021 Life Science
